This paper is in the following e-collection/theme issue:

Longitudinal and Cohort Studies in Public Health (316) JMIR Theme Issue: COVID-19 Special Issue (2461) Outbreak and Pandemic Preparedness and Management (1743) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1520) Infectious Diseases (non-STD/STI) (1592) Public (e)Health, Digital Epidemiology and Public Health Informatics (750) Innovative Methods in Public Health and Surveillance (336) Statistical Methods for Surveillance and Population Health (158) Public Health Informatics (93) Secondary Use of Clinical Data for Research and Surveillance (375) Chronic Conditions (278)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49841, first published .
Defining the Subtypes of Long COVID and Risk Factors for Prolonged Disease: Population-Based Case-Crossover Study

Defining the Subtypes of Long COVID and Risk Factors for Prolonged Disease: Population-Based Case-Crossover Study

Defining the Subtypes of Long COVID and Risk Factors for Prolonged Disease: Population-Based Case-Crossover Study

Authors of this article:

Skyler Resendez1 Author Orcid Image ;   Steven H Brown2 Author Orcid Image ;   Hugo Sebastian Ruiz Ayala1 Author Orcid Image ;   Prahalad Rangan1 Author Orcid Image ;   Jonathan Nebeker2 Author Orcid Image ;   Diane Montella2 Author Orcid Image ;   Peter L Elkin1, 2 Author Orcid Image
Article Authors Cited by (1) Tweetations (4) Metrics

Journals

  1. Rivera‐Caravaca J, Frost F, Marín F, Lip G. Impact of prior oral anticoagulation therapies on post‐discharge outcomes after COVID‐19: Results from a global federated health network analysis. European Journal of Clinical Investigation 2024;54(12) View